Mehmet Oz, President Trump’s pick to lead the CMS, said Medicare beneficiaries should have quicker access to new medical ...

In most cases, Abbott is one of three or four competitors that dominate the market, including nutrition, cardiac rhythm management devices, surgical heart valves, continuous glucose monitors, coronary ...

Abbott Laboratories is undervalued with strong growth in diabetes care and weight-loss markets. Discover why ABT stock is a ...

Capstan Medical, a startup focused on robotic-assisted mitral and tricuspid valve replacement, recently completed its first ...

the launch of new products like the GridX mapping catheter, and strong momentum in structural heart devices, including MitraClip and TriClip.

Mehmet Oz, President Donald Trump’s nominee to lead Medicare and Medicaid, told senators he would focus on chronic disease ...